Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bebo HealthXPAR:MLBBO 47 3-Year ROIIC % is -1.53 as of Dec. 2025. GuruFocus rates XPAR:MLBBO with a GF Score™ of 47/100 and a GF Value™ of €0.03 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 1,057 Retail - Cyclical companies, Bebo Health ranks worse than 62.63% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Bebo Health's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -1.53%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Bebo Health's 3-Year ROIIC % or its related term are showing as below:
XPAR:MLBBO's 3-Year ROIIC % is ranked worse than 62.63% of 1057
companies
in the Retail - Cyclical industry
Industry Median: 4.63
vs XPAR:MLBBO: -1.53
Bebo Health (XPAR:MLBBO) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Bebo Health 3-Year ROIIC % Related Terms
Bebo Health 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Bebo Health's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:MLBBO vs CASY, WSM, DKS: 3-Year ROIIC % Comparison
For the Specialty Retail subindustry, Bebo Health's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bebo Health 3-Year ROIIC % vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Bebo Health's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Bebo Health's 3-Year ROIIC % falls into.
Bebo Health's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 0.0301716 (Dec. 2025) - 0.336 (Dec. 2022) )
/
( 28.687 (Dec. 2025) - 8.746 (Dec. 2022) )
=
-0.3058284
/
19.941
=
-1.53%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Bebo Health (XPAR:MLBBO) has a 3-Year ROIIC % of -1.53 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Bebo Health and its competitors. According to the industry distribution chart, Bebo Health ranks #662 out of 1057 companies in the Retail - Cyclical industry, placing it in the top 62.6%.
Is Bebo Health's 3-Year ROIIC % too high?
Bebo Health's current 3-Year ROIIC % is -1.53. Based on the distribution chart, Bebo Health ranks #662 out of 1057 companies in the Retail - Cyclical industry, which is below the industry midpoint. Overall, Bebo Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bebo Health's 3-Year ROIIC % compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Bebo Health ranks #662 out of 1057 companies for 3-Year ROIIC %. This places Bebo Health in the lower half of its industry. The industry median 3-Year ROIIC % is 4.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Retail - Cyclical company?
The median 3-Year ROIIC % among Retail - Cyclical companies is 4.63, based on 1,057 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Bebo Health and its competitors. For the Retail - Cyclical industry, the median 3-Year ROIIC % is 4.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bebo Health's current 3-Year ROIIC % is -1.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bebo Health stock overvalued right now?
Based on GuruFocus' analysis, Bebo Health (XPAR:MLBBO) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.03, compared to a current price of €0.18 — trading 513.3% above its estimated fair value. The current 3-Year ROIIC % is -1.53. Bebo Health's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Bebo Health (XPAR:MLBBO), the current 3-Year ROIIC % is -1.53 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bebo Health (XPAR:MLBBO) Overvalued in 2026?
Based on GuruFocus' analysis, Bebo Health stock appears to be overvalued.
The current stock price of €0.18 is trading 513.3% above its estimated GF Value™ of €0.03.
GuruFocus considers Bebo Health to be Significantly Overvalued.
Key valuation signals for XPAR:MLBBO:
3-Year ROIIC %: -1.53
GF Value™: €0.03 vs. price of €0.18 (513.3% above fair value)
No single metric tells the full story. See the XPAR:MLBBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLBBO has been successfully added to your 
